Product Features
• FDA Approved
• SAMHSA Cut-off Levels
• Administrator Activated
• Split-specimen
• Results in Minutes
Product Links
• click here for package insert
• click here for package insert (CLIA)
• click here for product procedure
• click here for result form
The Integrated E-Z Split Key® Cup II is a lateral flow chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in urine at the cut-off concentrations listed below. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in urine.
Available Configurations
DUD-157-012-19
(COC, AMP, mAMP, THC, OPI) + (pH, S.G., OX, NIT, GLUT, CRE)(CLIA WAIVED)
25/BOX
DUD-157-023-19
(COC, AMP, THC, OPI, PCP) + (pH, S.G., OX, NIT, GLUT, CRE)(CLIA WAIVED)
25/BOX
Cut-off Levels
AMP
AMPHETAMINE
1,000
ng/mL
BAR
BARBITURATES
300
ng/mL
BZO
BENZODIAZEPINES
300
ng/mL
BUP
BUPRENORPHINE
10
ng/mL
COC
COCAINE
300
ng/mL
THC
MARIJUANA
50
ng/mL
MTD
METHADONE
300
ng/mL
mAMP
METHAMPHETAMINE
1,000
ng/mL
MDMA
METHYLENEDIOXYMETHAMPHETAMINE
500
ng/mL
MOP
MORPHINE (OPIATE 300)
300
ng/mL
OPI
OPIATES
2,000
ng/mL
OXY
OXYCODONE
100
ng/mL
PCP
PHENCYCLIDINE
25
ng/mL
PPX
PROPOXYPHENE
300
ng/mL
TCA
TRICYCLIC ANTIDEPRESSANTS
1,000
ng/mL
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.